Hepatitis C Virus Elimination by 2030: Conquering Mount Improbable.
作者信息
Dhiman Radha K, Premkumar Madhumita
机构信息
Department of Hepatology Postgraduate Institute of Medical Education and Research Chandigarh India.
Mukh-Mantri Punjab Hepatitis C Relief Fund Punjab Government Punjab India.
出版信息
Clin Liver Dis (Hoboken). 2021 Jan 13;16(6):254-261. doi: 10.1002/cld.978. eCollection 2020 Dec.
Abstract
摘要
相似文献
1
Hepatitis C Virus Elimination by 2030: Conquering Mount Improbable.
Clin Liver Dis (Hoboken). 2021 Jan 13;16(6):254-261. doi: 10.1002/cld.978. eCollection 2020 Dec.
2
Challenges Facing Viral Hepatitis C Elimination in Lebanon.
Pathogens. 2023 Mar 9;12(3):432. doi: 10.3390/pathogens12030432.
3
The global hepatitis delta virus (HDV) epidemic: what gaps to address in order to mount a public health response?
Arch Public Health. 2021 Oct 19;79(1):180. doi: 10.1186/s13690-021-00693-2.
4
Hepatitis C and Human Immunodeficiency Virus Kidney Transplantation: The Mount Sinai Experience.
Clin Transpl. 2015;31:69-78.
5
Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C.
Gastroenterology. 1999 Oct;117(4):933-41. doi: 10.1016/s0016-5085(99)70353-7.
6
[Physiological aspects of conquering of the Mount Everest].
Cas Lek Cesk. 1954 Jun 11;93(24):664-6.
7
[Hepatitis C virus: an improbable etiological agent of Gougerot-Sjögren's syndrome].
Presse Med. 1993 Jun 26;22(23):1108.
8
Role of the specific T-cell response for clearance and control of hepatitis C virus.
J Viral Hepat. 1999 Jul;6 Suppl 1:36-40. doi: 10.1046/j.1365-2893.1999.00006.x.
9
The 11th Canadian Symposium on Hepatitis C Virus: 'Getting back on track towards hepatitis C elimination'.
Can Liver J. 2023 Feb 28;6(1):56-69. doi: 10.3138/canlivj-2022-0034. eCollection 2023 Feb.
10
The Elimination of Hepatitis C as a Public Health Threat.
Cold Spring Harb Perspect Med. 2020 Apr 1;10(4):a036939. doi: 10.1101/cshperspect.a036939.
引用本文的文献
1
Early Postnatal Polymerase Chain Reaction Testing in the Identification of Perinatal Transmission of Hepatitis C Virus.
Clin Infect Dis. 2025 Jul 14. doi: 10.1093/cid/ciaf266.
2
Impact of Resistance Associated Substitutions and Predictors of Treatment Failure Following Direct-acting Antiviral Therapy in a Viral Hepatitis C Elimination Cohort.
J Clin Exp Hepatol. 2025 Nov-Dec;15(6):102601. doi: 10.1016/j.jceh.2025.102601. Epub 2025 May 28.
3
Hepatitis B and C virus infection and risk of multiple myeloma: a systematic review and meta-analysis.
BMC Cancer. 2025 Jun 4;25(1):998. doi: 10.1186/s12885-025-14420-5.
4
Autoantibodies to apolipoprotein A-I in hepatitis C virus infection: a role in disease progression?
Front Immunol. 2025 Mar 20;16:1461041. doi: 10.3389/fimmu.2025.1461041. eCollection 2025.
5
Anonymous Opt-Out HIV and hepatitis C screening at a syringe services program in Florida.
Harm Reduct J. 2025 Mar 12;22(1):30. doi: 10.1186/s12954-025-01182-3.
6
Outcomes of Low Barrier Hepatitis C Treatment in High Risk Populations From Primary Care.
J Community Hosp Intern Med Perspect. 2024 Nov 2;14(6):10-17. doi: 10.55729/2000-9666.1404. eCollection 2024.
7
Closing the Gaps in Hepatitis C Knowledge Among Internal Medicine Residents in the United States.
Am J Med Open. 2024 Aug 13;12:100077. doi: 10.1016/j.ajmo.2024.100077. eCollection 2024 Dec.
8
Optimizing Hepatitis C Treatment Monitoring: Is Sustained Virologic Response at 4 Weeks Becoming the New Standard?
Microorganisms. 2024 Oct 10;12(10):2050. doi: 10.3390/microorganisms12102050.
9
Performance of Elecsys HCV Duo Immunoassay for Diagnosis and Assessment of Treatment Response in HCV Patients with or without HIV Infection.
Diagnostics (Basel). 2024 Sep 29;14(19):2179. doi: 10.3390/diagnostics14192179.
10
United States Provider Experiences With Telemedicine for Hepatitis C Treatment: A Nationwide Survey.
J Viral Hepat. 2024 Dec;31(12):873-879. doi: 10.1111/jvh.14010. Epub 2024 Oct 1.
本文引用的文献
1
Three Years of Progress Toward Achieving Hepatitis C Elimination in the Country of Georgia, April 2015-March 2018.
Clin Infect Dis. 2020 Aug 22;71(5):1263-1268. doi: 10.1093/cid/ciz956.
2
Real-world cost-effectiveness of pan-genotypic Sofosbuvir-Velpatasvir combination versus genotype dependent directly acting anti-viral drugs for treatment of hepatitis C patients in the universal coverage scheme of Punjab state in India.
PLoS One. 2019 Aug 29;14(8):e0221769. doi: 10.1371/journal.pone.0221769. eCollection 2019.
3
Countermeasures against viral hepatitis B and C in Japan: An epidemiological point of view.
Hepatol Res. 2019 Sep;49(9):990-1002. doi: 10.1111/hepr.13417. Epub 2019 Aug 22.
4
Decentralized care with generic direct-acting antivirals in the management of chronic hepatitis C in a public health care setting.
J Hepatol. 2019 Dec;71(6):1076-1085. doi: 10.1016/j.jhep.2019.07.006. Epub 2019 Jul 17.
5
Changes in hepatitis C burden and treatment trends in Europe during the era of direct-acting antivirals: a modelling study.
BMJ Open. 2019 Jun 11;9(6):e026726. doi: 10.1136/bmjopen-2018-026726.
6
The impact of direct-acting anti-virals on the hepatitis C care cascade: identifying progress and gaps towards hepatitis C elimination in the United States.
Aliment Pharmacol Ther. 2019 Jul;50(1):66-74. doi: 10.1111/apt.15291. Epub 2019 May 22.
7
Alternative State-Level Financing for Hepatitis C Treatment-The "Netflix Model".
JAMA. 2018 Nov 20;320(19):1977-1978. doi: 10.1001/jama.2018.15782.
8
Direct-acting antiviral Therapy Is Safe and Effective in Pediatric Chronic Hepatitis C: The Public Health Perspective.
J Pediatr Gastroenterol Nutr. 2019 Jan;68(1):74-80. doi: 10.1097/MPG.0000000000002139.
9
Real-world outcomes of unrestricted direct-acting antiviral treatment for hepatitis C in Australia: The South Australian statewide experience.
J Viral Hepat. 2018 Nov;25(11):1287-1297. doi: 10.1111/jvh.12943. Epub 2018 Jul 10.
10
Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial.
Lancet Gastroenterol Hepatol. 2018 Mar;3(3):153-161. doi: 10.1016/S2468-1253(17)30404-1. Epub 2018 Jan 6.
Zotero 插件